Regulatory Forum Opinion Piece: Carcinogen Risk Assessment
暂无分享,去创建一个
[1] A. Boobis,et al. Evaluation of the utility of the lifetime mouse bioassay in the identification of cancer hazards for humans. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[2] H Enzmann,et al. The significance of mouse liver tumor formation for carcinogenic risk assessment: results and conclusions from a survey of ten years of testing by the agrochemical industry. , 1997, Environmental health perspectives.
[3] Carolyn Vickers,et al. IPCS framework for analysing the relevance of a cancer mode of action for humans , 2006 .
[4] Mathieu Vinken,et al. The adverse outcome pathway concept: a pragmatic tool in toxicology. , 2013, Toxicology.
[5] Melvin E Andersen,et al. Toxicity testing in the 21st century: bringing the vision to life. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.
[6] Shanna H. Swan. Prenatal Phthalate Exposure and Anogenital Distance in Male Infants , 2006, Environmental health perspectives.
[7] J. McLachlan,et al. Vaginal adenosis and adenocarcinoma in mice exposed prenatally or neonatally to diethylstilbestrol. , 1982, Cancer research.
[8] P. Fu,et al. Neonatal mouse assay for tumorigenicity: alternative to the chronic rodent bioassay. , 1997, Regulatory toxicology and pharmacology : RTP.
[9] M Younes,et al. IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis. , 2001, Regulatory toxicology and pharmacology : RTP.
[10] Carla Mattos,et al. A comprehensive survey of Ras mutations in cancer. , 2012, Cancer research.
[11] Karen Lowrie,et al. Toxicity testing in the 21st century. , 2009, Risk analysis : an official publication of the Society for Risk Analysis.
[12] C. Peter,et al. The Value of Historical Control Data , 1988 .
[13] A. J. Lehman,et al. Procedures for the appraisal of the toxicity of chemicals in foods. , 1949, Food, Drug, cosmetic law quarterly.
[14] J. Bailar,et al. Toxicity Testing in the 21st Century: A Vision and a Strategy , 2010, Journal of toxicology and environmental health. Part B, Critical reviews.
[15] M. Soffritti,et al. Life-Span Exposure to Low Doses of Aspartame Beginning during Prenatal Life Increases Cancer Effects in Rats , 2007, Environmental health perspectives.
[16] Ulrich Mohr,et al. The Value of Historical Control Data—Scientific Advantages for Pathologists, Industry and Agencies , 2002, Toxicologic pathology.
[17] C L Alden,et al. A Critical Review of the Effectiveness of Rodent Pharmaceutical Carcinogenesis Testing in Predicting for Human Risk , 2011, Veterinary pathology.
[18] J. Huff,et al. The Limits of Two-Year Bioassay Exposure Regimens for Identifying Chemical Carcinogens , 2008, Environmental health perspectives.
[19] Douglas C. Wolf,et al. Best Practices for Use of Historical Control Data of Proliferative Rodent Lesions , 2009, Toxicologic pathology.
[20] J. Bailar,et al. Toxicity testing in the 21st century—a vision and a strategy , 2012 .
[21] Yvonne Will,et al. Evaluation of drugs with specific organ toxicities in organ-specific cell lines. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.
[22] N. Tamaoki,et al. The rasH2 Transgenic Mouse: Nature of the Model and Mechanistic Studies on Tumorigenesis , 2001, Toxicologic pathology.
[23] B. Shapiro,et al. Neonatal phenobarbital imprints overexpression of cytochromes P450 with associated increase in tumorigenesis and reduced life span , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[24] A. Jacobs. Prediction of 2-year carcinogenicity study results for pharmaceutical products: how are we doing? , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[25] E. Mcconnell. The Maximum Tolerated Dose: The Debate , 1989 .
[26] R L Kodell,et al. A review of mammalian carcinogenicity study design and potential effects of alternate test procedures on the safety evaluation of food ingredients. , 2011, Regulatory toxicology and pharmacology : RTP.
[27] L. Gold,et al. Supplement to the Carcinogenic Potency Database (CPDB): results of animal bioassays published in the general literature through 1997 and by the National Toxicology Program in 1997-1998. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[28] Daniel Morton,et al. An Analysis of Pharmaceutical Experience with Decades of Rat Carcinogenicity Testing , 2011, Toxicologic pathology.
[29] B. Tóth. A critical review of experiments in chemical carcinogensis using newborn animals. , 1968, Cancer research.
[30] P. Nambiar,et al. Spontaneous Tumor Incidence in rasH2 Mice , 2012, Toxicologic pathology.
[31] T. Hartung. Toxicology for the twenty-first century , 2009, Nature.
[32] K. Olejniczak,et al. Evaluation of carcinogenicity studies of medicinal products for human use authorised via the European centralised procedure (1995-2009). , 2011, Regulatory toxicology and pharmacology : RTP.
[33] A. Jacobs,et al. History of Chronic Toxicity and Animal Carcinogenicity Studies for Pharmaceuticals , 2013, Veterinary pathology.
[34] F. Sistare,et al. An Evaluation of Chronic 6- and 12-Month Rat Toxicology Studies as Predictors of 2-Year Tumor Outcome , 2010, Veterinary pathology.
[35] George E. P. Box,et al. Intervention Analysis with Applications to Economic and Environmental Problems , 1975 .
[36] A. Kolbye,et al. A critique of the use of the maximum tolerated dose in bioassays to assess cancer risks from chemicals. , 1991, Regulatory toxicology and pharmacology : RTP.
[37] Angelo Moretto,et al. A Tiered Approach to Systemic Toxicity Testing for Agricultural Chemical Safety Assessment , 2006, Critical reviews in toxicology.
[38] Jan Herrmann,et al. A tiered approach. , 2013, Nature nanotechnology.
[39] R. Jirtle,et al. Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development , 2007, Proceedings of the National Academy of Sciences.
[40] M. Soffritti,et al. Life-time carcinogenicity bioassays of toluene given by stomach tube to Sprague-Dawley rats Studi di cancerogenicità a lungo termine del toluene somministrato mediante sonda gastrica a ratti Sprague-Dawley , 2004 .
[41] L. Gold,et al. Supplement to the Carcinogenic Potency Database (CPDB): results of animal bioassays published in the general literature in 1993 to 1994 and by the National Toxicology Program in 1995 to 1996. , 1999, Environmental health perspectives.
[42] J. P. Van Oosterhout,et al. The utility of two rodent species in carcinogenic risk assessment of pharmaceuticals in Europe. , 1997, Regulatory toxicology and pharmacology : RTP.
[43] J. Haseman,et al. An examination of the association between maximum-tolerated dose and carcinogenicity in 326 long-term studies in rats and mice. , 1992, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[44] J. Ward. The Two-Year Rodent Carcinogenesis Bioassay — Will It Survive? , 2007 .
[45] L Tomatis,et al. Carcinogenesis bioassays: study duration and biological relevance. , 2001, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[46] Cheryl A Murphy,et al. Development and application of the adverse outcome pathway framework for understanding and predicting chronic toxicity: I. Challenges and research needs in ecotoxicology. , 2015, Chemosphere.
[47] A. Apostolou. Relevance of maximum tolerated dose to human carcinogenic risk. , 1990, Regulatory toxicology and pharmacology : RTP.
[48] J. L. Bos,et al. ras oncogenes in human cancer: a review. , 1989, Cancer research.
[49] Lester B Lave,et al. Implications of the lack of accuracy of the lifetime rodent bioassay for predicting human carcinogenicity. , 2003, Regulatory toxicology and pharmacology : RTP.
[50] H. Leffers,et al. Testicular dysgenesis syndrome and the origin of carcinoma in situ testis. , 2008, International journal of andrology.
[51] R. Jackson. Toxicity prediction from metabolic pathway modelling. , 1995, Toxicology.
[52] L. Bernstein,et al. Interspecies extrapolation in carcinogenesis: prediction between rats and mice. , 1989, Environmental health perspectives.
[53] D. Casciano,et al. Neonatal Mouse Model: Review of Methods and Results , 2001, Toxicologic pathology.
[54] J. Huff,et al. Long‐Term Chemical Carcinogenesis Bioassays Predict Human Cancer Hazards: Issues, Controversies, and Uncertainties , 1999, Annals of the New York Academy of Sciences.
[55] Christina Chan,et al. Systems biology for identifying liver toxicity pathways , 2009, BMC proceedings.
[56] C. Alden,et al. A Critical Appraisal of the Value of the Mouse Cancer Bioassay in Safety Assessment , 1996, Toxicologic pathology.
[57] M. Greenberg,et al. Toxicity Testing in the 21st Century , 2009, Risk analysis : an official publication of the Society for Risk Analysis.
[58] S. Cohen,et al. Alternative models for carcinogenicity testing. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.